Cancer Research UK has revealed that in the UK alone in 2013 there were in excess of 330,000 cancer diagnoses. X-ray CT, MRI and LINAC systems are widely used in cancer radiotherapy planning and treatment.
Medibord Ltd produces patented radiotherapy positioning products which are used by healthcare professionals worldwide to accurately and reproducibly locate and treat a patient’s cancerous cells which is critical for effective treatment. Based on technical and market research Medibord has identified three potentially significant product enhancements which could further enhance the long term outcomes for patients. These enhancements focus on accuracy, healthcare workflow management and patient safety which as well as improving health economics and patient outcomes enhance the IP/commercial position for Medibord.
20,580
2016-12-01 to 2017-03-31
Feasibility Studies
Cancer Research UK has revealed that in the UK alone in 2013 there were in excess of 330,000 cancer
diagnoses. X-ray CT, MRI and Linac systems are widely used in cancer radiotherapy planning and
treatment. Medibord Ltd produces patented radiotherapy positioning products which are used by
healthcare professionals worldwide to accurately and reproducibly locate and treat a patient’s cancerous
cells which is critical for effective treatment. Based on technical and market research Medibord has
identified a potentially significant product enhancement which could further enhance the long term
outcomes for patients through the use of robotic surgery.
24,750
2014-08-01 to 2014-11-30
Feasibility Studies
Cancer Research UK has revealed that in the UK alone in 2013 there were in excess of 330,000 cancer diagnoses. X-ray CT, MRI and Linac systems are widely used in cancer radiotherapy planning and treatment. Medibord Ltd produces patented radiotherapy positioning products which are used by healthcare professionals worldwide to accurately and reproducibly locate and treat a patient’s cancerous cells which is critical for effective treatment. Based on technical and market research Medibord has identified a potentially significant product enhancement which could further enhance the long term outcomes for patients by ensuring that additional radiation exposure does not occur as a result of imaging and treatment. This additional radiation is responsible for secondary cancers in a number of cases.
24,750
2013-07-01 to 2013-10-31
Feasibility Studies
There is an Increase in the use of MRI, CT, PET, PET/CT and Linac technology to resolve and treat complex medical problems such as cancer. Medibord provides solutions for radiotherapy needs, such as, customised MRI compatible couch tops. Medibord does not heat up by induction, thereby avoiding excessive heat to the skin of the patient during treatment. The new business model moves away from manual to automotive manufacturing. This feasibility study looks at 3-D printing and coatings by find possible candidates to improve current marketing and perceived product value.